Literature DB >> 2991111

The prevalence of carcinoma in situ in normal and cancer-associated breasts.

C E Alpers, S R Wellings.   

Abstract

Two hundred ninety-two human breasts were examined in toto by a subgross sampling technique with histologic confirmation. The samples consisted of 185 breasts from random autopsies, 63 cancer-containing breasts, and 44 breasts contralateral to cancer-containing breasts. The method permits the identification and enumeration of essentially all of the dysplastic, hyperplastic, and neoplastic lesions present in each breast. Emphasis was on the prevalence within each sample category of ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), and epithelial proliferative lesions with severe atypia, previously termed ALA 4 and ALB 4, which correspond to the clinicopathologic entities atypical ductal hyperplasia and atypical lobular hyperplasia, respectively. Additional primary foci of DCIS (unrelated to invasive breast carcinoma, if present) were found in 52.5 per cent of cancer-containing breasts, and were seen in 47.7 per cent of contralateral and 5.9 per cent of the breasts from random autopsies. Lobular carcinoma in situ was generally seen only in association with infiltrating carcinoma, usually of the ductal type. No LCIS was seen in the breasts from random autopsies. These trends are the same if the proliferative lesions with severe atypia are included with carcinoma in situ. The numbers of lesions were also markedly greater in affected cancer-associated breasts than in affected breasts obtained from autopsies. These findings suggest that LCIS, although a rare lesion in the general population, may be a significant marker for clinical carcinoma. They support previous studies showing a small percentage of women with undetected DCIS of uncertain clinical and biological potential. The multicentric nature of preinvasive breast carcinoma is further substantiated. Finally, when the prevalence and number of lesions are considered in association with the ages of the patients, the lower prevalence of such lesions in the older patients in each sample suggests that at least some DCIS and LCIS may be dependent on a premenopausal hormonal milieu for their continuing existence.

Entities:  

Mesh:

Year:  1985        PMID: 2991111     DOI: 10.1016/s0046-8177(85)80251-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  29 in total

1.  An original stereomicroscopic analysis of the mammary glandular tree.

Authors:  D Faverly; R Holland; L Burgers
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Atypical hyperplasia and breast cancer risk: a critique.

Authors:  L Ma; N F Boyd
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

3.  Reconstruction of functionally normal and malignant human breast tissues in mice.

Authors:  Charlotte Kuperwasser; Tony Chavarria; Min Wu; Greg Magrane; Joe W Gray; Loucinda Carey; Andrea Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

4.  What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?

Authors:  F Sardanelli; L Bacigalupo; L Carbonaro; A Esseridou; G M Giuseppetti; P Panizza; V Lattanzio; A Del Maschio
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

5.  A developmental hypothesis to explain the multicentricity of breast cancer.

Authors:  C R Sharpe
Journal:  CMAJ       Date:  1998-07-14       Impact factor: 8.262

Review 6.  Will screening mammography in the East do more harm than good?

Authors:  Gabriel M Leung; Tai-Hing Lam; Thuan Q Thach; Anthony J Hedley
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

7.  Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway.

Authors:  Xianmin Luo; Megan K Ruhland; Ermira Pazolli; Anne C Lind; Sheila A Stewart
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

8.  Biologic characteristics of premalignant breast disease.

Authors:  Kimberly Cole; Maria Tabernero; Karen S Anderson
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 9.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 10.  Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy.

Authors:  Ute Kettritz
Journal:  Eur Radiol       Date:  2007-09-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.